Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (PLCH2) is a member of the phospholipase C (PLC) family, specifically the eta subfamily, which is characterized by a unique C-terminal domain (UniProt: Q8IVC7). It functions as an enzyme that catalyzes the calcium-dependent hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) (NCBI Gene: 155061). These products are essential for intracellular calcium mobilization and the activation of protein kinase C, facilitating various signal transduction pathways. PLCH2 is predominantly expressed in the retina and specific regions of the brain, such as the cerebellum and hippocampus, indicating a specialized role in sensory and neuronal signaling (PubMed: 15159411). Research suggests its involvement in the regulation of neurite outgrowth and potentially in the pathophysiology of certain cancers and neurological disorders (PubMed: 24333146). Currently, there are no approved drugs specifically targeting PLCH2, though it remains a target of interest for modulating calcium-sensitive signaling in specific tissues. Its high expression in the visual system suggests it may play a role in phototransduction or retinal maintenance.
Hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) in a calcium-dependent manner.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (PLCH2) (PLCH2).